HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Gynecologic oncologists seek balance as cervical cancer screening guidelines evolve Jennifer R. Southall
-
- Should HPV self-testing be usual care in the US?
- Not sure how much more breathless enthusiasm I can take Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- Advances in treatments for genitourinary malignancies provide silver lining to 2020 Monika Joshi, MD, MRCP
- Low trial participation rates slow development of myelodysplastic syndrome treatments Jennifer Byrne
- First-line nivolumab-cabozantinib superior to sunitinib for advanced renal cell carcinoma John DeRosier
- Ipatasertib plus abiraterone improves radiographic PFS in prostate cancer with PTEN loss John DeRosier
- Data reinforce adjuvant osimertinib as ‘practice-changing treatment’ in NSCLC subset Jennifer R. Southall
- Neoadjuvant atezolizumab, chemotherapy improve outcomes in triple-negative breast cancer Alexandra (Sasha) Todak
-
- Nivolumab regimen superior to chemotherapy alone in advanced gastric, esophageal cancers John DeRosier
- Pembrolizumab regimen superior to chemotherapy alone in advanced esophageal cancer John DeRosier
- Steroids may improve mogamulizumab efficacy for cutaneous T-cell lymphoma Mark Leiser
- Dihydroorotate dehydrogenase inhibitors may increase chemotherapy effectiveness in AML John DeRosier
- Endotheliopathy in COVID-19 linked to severe illness, mortality Jennifer R. Southall
- Selpercatinib effective, safe in RET-altered thyroid cancer, NSCLC John DeRosier
- Vitamin D may reduce risk for immune checkpoint inhibitor-induced colitis John DeRosier
- DNA repair-gene variants linked to subsequent neoplasm risk in pediatric cancer survivors Jennifer R. Southall
-
- FDA approves Darzalex-based regimen for relapsed, refractory multiple myeloma
- FDA grants breakthrough therapy designation to RC48 for urothelial cancer
- LUNGevity Foundation presents career development awards
- Roswell Park names senior VP of clinical investigation